{"protocolSection":{"identificationModule":{"nctId":"NCT06477484","orgStudyIdInfo":{"id":"2024SF35"},"organization":{"fullName":"Peking University First Hospital","class":"OTHER"},"briefTitle":"Blood Biomarkers for Screening of Alzheimer's Disease","officialTitle":"Blood-based Biomarkers for Early Alzheimer's Disease Screening"},"statusModule":{"statusVerifiedDate":"2024-06","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2024-06-18","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2026-03-26","type":"ESTIMATED"},"completionDateStruct":{"date":"2026-03-26","type":"ESTIMATED"},"studyFirstSubmitDate":"2024-06-06","studyFirstSubmitQcDate":"2024-06-26","studyFirstPostDateStruct":{"date":"2024-06-27","type":"ACTUAL"},"lastUpdateSubmitDate":"2024-06-26","lastUpdatePostDateStruct":{"date":"2024-06-27","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Peking University First Hospital","class":"OTHER"}},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The goal of this observational study is to estimate the screen performance of blood biomarkers of interest (Aβ40 and Aβ42, P-Tau181, P-Tau217, GFAP and NfL) in patients with Alzheimer's disease (AD), mild cognitive impairment due to AD, and cognitively normal individuals. The main questions it aims to answer are:\n\n* to identify core blood biomarker suitable for early screening of AD.\n* to establish a comprehensive model for the early identification of AD."},"conditionsModule":{"conditions":["Alzheimer's Disease","Blood Biomarkers"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"COHORT","timePerspective":"CROSS_SECTIONAL"},"enrollmentInfo":{"count":180,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"different stages of individuals with Alzheimer's disease","interventionNames":["Diagnostic Test: Blood biomarker"]}],"interventions":[{"type":"DIAGNOSTIC_TEST","name":"Blood biomarker","description":"Blood biomarker","armGroupLabels":["different stages of individuals with Alzheimer's disease"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Evaluate the diagnostic accuracy of blood biomarkers of Aβ42, Aβ40, Aβ42/Aβ40, P-Tau181, P-Tau217, GFAP and NfL.","timeFrame":"2 years"}],"secondaryOutcomes":[{"measure":"Evaluate the diagnostic accuracy of a comprehensive model combined with core blood biomarkers and clinical information.","timeFrame":"2 years"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age ≥ 50 years;\n* AD (meets the 2011 NIA-AA AD diagnostic criteria), or MCI (meets the 2004 Peterson MCI diagnostic criteria), or cognitively normal subjects;\n* Signed informed consent form.\n\nExclusion Criteria:\n\n* The presence of other disorders that can cause cognitive impairment;\n* Unable to cooperate with the completion of cognitive assessment;\n* Refusal to draw blood.","healthyVolunteers":true,"sex":"ALL","minimumAge":"50 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Alzheimer's disease, mild cognitive impairment due to AD, and cognitively normal individuals.","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"centralContacts":[{"name":"Chen Zhang","role":"CONTACT","phone":"86+83572462","email":"chenzizm@126.com"}],"locations":[{"facility":"Peking University First Hospital","status":"RECRUITING","city":"Beijing","state":"Beijing","zip":"100034","country":"China","contacts":[{"name":"Chen Zhang, PhD","role":"CONTACT"}],"geoPoint":{"lat":39.9075,"lon":116.39723}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-07-01"},"conditionBrowseModule":{"meshes":[{"id":"D000000544","term":"Alzheimer Disease"}],"ancestors":[{"id":"D000003704","term":"Dementia"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000024801","term":"Tauopathies"},{"id":"D000019636","term":"Neurodegenerative Diseases"},{"id":"D000019965","term":"Neurocognitive Disorders"},{"id":"D000001523","term":"Mental Disorders"}],"browseLeaves":[{"id":"M3885","name":"Alzheimer Disease","asFound":"Alzheimer's Disease","relevance":"HIGH"},{"id":"M6904","name":"Dementia","relevance":"LOW"},{"id":"M5204","name":"Brain Diseases","relevance":"LOW"},{"id":"M5742","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M23002","name":"Tauopathies","relevance":"LOW"},{"id":"M21558","name":"Neurodegenerative Diseases","relevance":"LOW"},{"id":"M21836","name":"Neurocognitive Disorders","relevance":"LOW"},{"id":"M14473","name":"Psychotic Disorders","relevance":"LOW"},{"id":"M4815","name":"Mental Disorders","relevance":"LOW"},{"id":"T2192","name":"Familial Alzheimer Disease","asFound":"Alzheimer's Disease","relevance":"HIGH"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BXM","name":"Behaviors and Mental Disorders"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}